$AstraZeneca (AZN.US)$ Ultomiris now approved for Tx of neu...
$AstraZeneca(AZN.US$ Ultomiris now approved for Tx of
neuromyelitis optica spectrum disorder (NMOSD)![]()
neuromyelitis optica spectrum disorder (NMOSD)
⇒ sBLA approved as 4th indication 👏
⇒ 1st and only long-acting C5 complement inhibitor,
offers Px with AQP4 Ab+
⇒ CHAMPION-NMOSD trial - met primary endpoint 🔬
⇒ Ultomiris (ravulizumab-cwvz) inj., for IV use 💉
⇒ 1st and only long-acting C5 complement inhibitor,
offers Px with AQP4 Ab+
⇒ CHAMPION-NMOSD trial - met primary endpoint 🔬
⇒ Ultomiris (ravulizumab-cwvz) inj., for IV use 💉
![$AstraZeneca (AZN.US)$ Ultomiris now approved for Tx of neuromyelitis optica spectrum disorder (NMOSD) [Cheerlead] ⇒ sBLA approved as 4th indication 👏 ⇒ 1st ...](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240327/2f0143b6d6f647b8b9e441c9626baec3.png/big?area=100&is_public=true)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
